Hypertension is related to sodium intake, and many patients with essential hypertension are overweight and have the metabolic syndrome. We therefore studied microsatellite markers close to the thiazide-sensitive Na-Cl cotransporter on chromosome 16 and a quantitative trait locus for abdominal obesity-metabolic syndrome (AOMS2) on chromosome 17, which have been found to be linked to hypertension in a previous genome scan in Chinese. There were 84 hypertensive subjects (44 men, 40 women, age 53713 years) and 88 normotensive controls (40 men, 48 women, age 54713 years) recruited. Specific oligonucleotide primers were used to amplify genomic DNA spanning the microsatellite markers D16S3396 and D17S1303 that consist of ATA and GATA repeats, respectively. We did not find any association between D16S3396 and blood pressure. In contrast, the distribution of D17S1303 genotypes differed between hypertensive subjects and normal controls (P ¼ 0.014). The number of GATA repeats correlated inversely with diastolic blood pressure (r ¼ À0.18, P ¼ 0.02) and body mass index (r ¼ À0.12, P ¼ 0.01). Nine GATA repeats in D17S1303 were associated with hypertension (OR 2.19, 95% CI 1.08-4.44, P ¼ 0.027), while 14 GATA repeats were associated with normotension (OR 0.26, 95% CI 0.10-0.66, P ¼ 0.002). The diastolic blood pressure in those with or without the (GATA)9 allele was 85.9713.6 and 79.2713.6 mmHg respectively (P ¼ 0.01), and in those with or without the (GATA)14 allele it was 73.8711.0 and 81.8714.0 mmHg respectively (P ¼ 0.003). Our results provide further evidence that a gene predisposing to hypertension in Chinese is in the vicinity of the microsatellite D17S1303.
Introduction
Hypertension is present in one in five of Hong Kong adults. 1 Most patients with essential hypertension do not have a single identifiable cause. Instead, hypertension is likely to result from the interaction between genetic predisposition and environmental factors. 2 We have undertaken a follow-up study of over 1500 individuals from the Hong Kong Cardiovascular Risk Factor Prevalence Survey cohort (CRISPS2), and found an increase in the prevalence of hypertension and diabetes, accompanied by an increase in the waist circumference. 3 Systolic and diastolic blood pressure correlate more strongly with the waist circumference than body weight, body mass index (BMI) or waist-hip ratio. 4 An overweight person is 3.5 times more likely to have hypertension and 3.1 times more likely to have diabetes. In Hong Kong, there is a clear association between essential hypertension and abdominal obesity, both of which are components of the metabolic syndrome. A person who is hypertensive but not overweight is in the minority, whereas whichever gene that causes abdominal obesity may also give rise to hypertension, as well as other components of the metabolic syndrome.
While overweight leading to abdominal adiposity is the foremost lifestyle factor in the aetiology of hypertension, there is an association between urinary sodium excretion and diastolic blood pressure in hypertensive individuals in Hong Kong. 5, 6 A low-sodium diet reduces the blood pressure in hypertensive patients. 7 These findings led us to postulate that genes involved in the abdominal obesity-metabolic syndrome and sodium excretion might be associated with hypertension.
Accordingly, we studied two microsatellite markers that have the highest LOD scores in a genome scan of blood pressure-regulating genes carried out in Chinese sib pairs undertaken in Anhui in collaboration with Harvard University. 8 The markers (D16S3396 and D17S1303), which consist of ATA and GATA repeats respectively, are close to the thiazide-sensitive Na-Cl cotransporter on chromosome 16 and a quantitative trait locus for abdominal obesity-metabolic syndrome (AOMS2) on chromosome 17.
9,10
Methods A total of 84 newly diagnosed untreated hypertensive subjects were recruited from the Hypertension Clinic of a teaching hospital. They were included if their untreated systolic blood pressure was 140 mmHg or more, or the diastolic blood pressure was 90 mmHg or more on more than three separate occasions. A total of 88 normotensive controls matched for sex and age were chosen from the Hong Kong CRISPS2. 1, 3 The study was conducted with written informed consent and approval from the Faculty Ethics Committee. The characteristics of the subjects are shown in Table 1 .
DNA was extracted from 200 ml buffy coat with the QIAamp DNA mini kit (QIAGEN GmBH, Hilden, Germany).
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Fluorescent-labelled oligonucleotide primers, described in the National Center for Biotechnology Information (NCBI) Entrez Gene database, 12 spanning the microsatellite polymorphisms D16S3396 and D17S1303 were synthesised by Applied Biosystems (Foster City, CA, USA) ( Figure 1 Figure 2) . 13 The number of alleles and the distribution of these alleles in the Hong Kong Chinese population were determined in hypertensive subjects and normal controls. To confirm the number of nucleotide repeats, PCR products in a proportion of subjects were separated on 3.0% agarose gels, and the fragments were extracted from the gel by the QIAquick Gel Extraction kit (QIAGEN GmbH, Hilden, Germany) and sequenced.
Statistical analysis
Clinical characteristics between the hypertensive and normotensive control groups were compared using unpaired Student's t-test or w 2 test as appropriate. Genotype frequencies for each group were tested for Hardy-Weinberg equilibrium. The primary hypothesis tested was whether D16S3396 and D17S1303 were associated with hypertension using w 2 test. Further analyses, which were explanatory and hypothesis generating, were performed to correlate the number of tandem repeats with blood pressure and to identify which alleles were different in the two groups. To reduce Type 2 error due to false positives, these further tests were considered significant only if there was an overall significant difference. Allelic frequencies between the groups were compared in 2 Â 2 tables, from which odds ratios were calculated. If the expected frequency in a cell was less than 5, Fisher's exact test was used. Logistic regression was used to adjust the odds ratios for possible confounding factors. With the present sample size, there was 97% power to detect an odds ratio of 2.5 for common polymorphic alleles (frequency 40.2), and 86% power for uncommon alleles (frequency 0.1).
Results

D16S3396
In the study population, the number of ATA repeats ranged from 10 to 18 (Table 2 ). In the decreasing order of frequency, 15, 12, 16 and 13 repeats were commonly found, accounting for 80% of alleles. The distribution of this polymorphism did not differ between hypertensive subjects and normal controls (w 2 ¼ 6.74, 8 df, P ¼ 0.53). There was a trend towards more ATA repeats in hypertensive subjects 
D17S1303
In the study population, the number of GATA repeats ranged from eight to 17, the commonest being 12 or 13 repeats, found in 70% of alleles ( Table 2 ). The distribution of this polymorphism differed between hypertensive subjects and normal controls (w 2 ¼ 19.12, 8 df, P ¼ 0.014). Leaving out the (GATA)8 and (GATA)17 allelic frequencies, which were low, or combining them for analysis increases the level of significance (P ¼ 0.009 and 0.004, respectively). The number of GATA repeats correlated inversely with diastolic blood pressure (r ¼ À0.18, P ¼ 0.02) and BMI (r ¼ À0.12, P ¼ 0.01). Nine GATA repeats in D17S1303 were associated with hypertension (OR 2.19, 95% CI 1.08-4.44, P ¼ 0.027), while 14 GATA repeats were associated with normotension (OR 0.26, 95% CI 0.10-0.66, Figure 1 The DNA sequence of the (GATA)9 allele of the microsatellite D17S1303 with nine GATA repeats. Figure 2 Determining the number of tandem repeats with GeneScan. The horizontal axis is the number of base pairs, calibrated using standard size markers. The vertical axis is in arbitrary units. (a) A single peak at 228 base pairs indicating that the subject was homozygous and had 10 GATA repeats. (b) Two peaks at 224 and 236 base pairs, indicating nine and 12 GATA repeats, respectively, in this heterozygous subject. Table 2 ). The odds ratios derived from logistic regression are not substantially different after controlling for age, sex and other confounding variables. (GATA)9 correlated more with diastolic blood pressure (r ¼ 0.21, P ¼ 0.006) than systolic blood pressure (r ¼ 0.14, P ¼ 0.07). The diastolic blood pressure in those with or without the (GATA)9 allele was 85.9713.6 and 79.2713.6 mmHg, respectively (P ¼ 0.01). Similarly, (GATA)14 correlated with diastolic pressure (r ¼ À0.23, P ¼ 0.003) rather than systolic pressure (r ¼ À0.15, P ¼ 0.06). The diastolic blood pressure in those with or without the (GATA)14 allele was 73.8711.0 and 81.8714.0 mmHg, respectively (P ¼ 0.003). (GATA)9 correlated negatively with plasma potassium (r ¼ À0.20, P ¼ 0.02), while (GATA)14 correlated with it (r ¼ 0.20, P ¼ 0.02), but these correlations diminished after controlling for the difference in blood pressure. Neither allele was associated with the plasma sodium level.
Discussion
Our study showed that the microsatellite D17S1303 but not D16S3396 is associated with hypertension in Hong Kong Chinese.
D16S3396 lies close to the gene SLC12A3 that codes for the thiazide-sensitive Na-Cl cotransporter (NCCT).
12 NCCT is believed to be the principal mediator of sodium and chloride reabsorption in the distal convoluted tubule, accounting for a significant fraction of net renal sodium reabsorption. This cotransporter is the target of thiazide diuretics used in the treatment of hypertension. Mutations in this gene lead to Gitelman's syndrome. 9 We did not find an association between hypertension and this microsatellite, unlike the genome scan in Anhui. 8 However, the microsatellite marker is about 5 cM from the gene, so the contribution of SLC12A3 to hypertension is by no means excluded. At the same time, the positive linkage might have been with a hitherto unsuspected gene and not SLC12A3.
Negative results can be due to insufficient statistical power. In contrast to the low power of linkage analysis, association studies do not suffer from lack of power. Instead, the problem is false positivity because of the multitude of candidate genes. Large sample sizes exacerbate the problem. What is needed is replication of the results in a different setting or population, preferably using a different method, and publication and dissemination of positive and negative findings.
D17S1303 lies at the quantitative trait locus associated with AOMS2 at 17p12 on chromosome 17. 10 Metabolic syndrome is a clustering of abdominal obesity, high triglycerides, low levels of highdensity lipoprotein cholesterol (HDLC), high blood pressure and elevated fasting glucose levels.
14 The underlying metabolic abnormality is believed to be insulin resistance. Adipocytes in adipose tissues secrete adipokines such as leptin, adiponectin, resistin and acylation-stimulating protein (ASP) that regulate obesity. 15 For example, leptin suppresses appetite. Resistin decreases insulin sensitivity, while adiponectin increases it. ASP, a cleavage product of complement C3, stimulates triacylglycerol synthesis and its storage in adipocytes. Genome scan for the genetic determinants of the metabolic syndrome revealed two loci of interest, 3q27 and 17p12. 10 The former is close to the adiponectin gene. The latter, AOMS2, is related to plasma levels of leptin 10 and ASP. 16 As neither the gene coding for leptin nor ASP (C3) is located there, there is an as yet unidentified gene in this locus that determines abdominal obesity. This locus is also associated with hypertension, as shown in the genome scan in 258 Chinese sib-pairs in Anhui. 8 Our finding not only confirmed the previous observed linkage with hypertension in the genome scan, but also suggested an association with other components of the metabolic syndrome. The confirmation of an association of blood pressure with microsatellites in two different populations using complementary genetic approaches is encouraging. Taken together, the results suggest that the disease-causing gene is close to the microsatellite marker.
Interestingly, the number of GATA repeats correlates with blood pressure, raising the possibility that this microsatellite may be more than a marker in linkage disequilibrium with the disease-causing gene, and may even confer susceptibility to hypertension. While missense mutations in genes performing vital function are deleterious and uncommon, subtle variations in the noncoding sequences may affect blood pressure across a broad spectrum of individuals. Variations in the tandem repeat sequences in microsatellites are common and may affect gene transcription and regulation, perhaps by forming Z-DNA. 17 Our results should prompt the search and identification of the gene causing hypertension and the metabolic syndrome in this part of chromosome 17, although final proof would require study of the function and dysfunction of the gene. 18 Chromosome 17 has been studied in genome scans, 19, 20 but the region around D17S1303 has not been intensively studied and there is a lack of reports of single nucleotide polymorphisms or genes in its close proximity. In case-control studies, single nucleotide polymorphisms are better than microsatellite markers, which are highly polymorphic and require multiple statistical hypothesis testing. Further work will focus on sequencing this region and confirming its association or linkage with hypertension.
In summary, scan of the human genome has revealed the region 17p12 in chromosome 17 to contain a gene for the metabolic syndrome and hypertension. We found an association of a microsatellite polymorphism in this region with hypertension and obesity. Early prediction of the metabolic syndrome might prevent hypertension, diabetes, dysplidaemia and their complications. In the Finnish Diabetes Prevention Study, intensive lifestyle changes successfully reduced the onset of diabetes by 58% and improved other components of the metabolic syndrome. 21 Current drugs for hypertension and obesity are not ideal. Our findings may therefore be a starting point for research that leads to a new drug target for hypertension and the metabolic syndrome.
